A variety of human diseases including neuronal degeneration, diabetes, cardiac hypertrophy, vascular disorders, and cancer are associated with dysregulation of AKT signaling, and thus a great effort has been directed toward development of ATK inhibitors [77, 78]. The gene discussed is BTK; the disease is cardiac hypertrophy.